BRODA ACNE - salicylic acid gel 
Bentley Laboratories, LLC

----------

Drug Facts Active Ingredient

Salicylic acid 2%

Purpose

acne treatment

Keep out of reach of children

Keep out of reach of children.

 If swallowed, get medical help or contact a Poison Control Center right away.

Uses

Acne treatment and helps prevent new acne blemishes.

Warnings

For external use only.

When using this product

skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time.

Avoid contact with eyes. If contact occurs, flush thoroughly with water.

Directions

Inactive ingredients

Water, poloxamer 407, propylene glycol, PEG-400, laureth-4, menthol, bisabolol.

BRODA Acne Spot Treatment and Acne Treatment Pen Labels

Tough on acne

Gentle on your skin

Anti-acne IntelliGel™

BRODA Acne Spot Treatment

Broda Acne Treatment Pen

IntelliGel™ Technology
Suitable for sensitive skin

Maximum strength with 2% beta hydrox acid
Forms TrueSkin invisible patch
No peeling or flaking

Won't dry your skin

Alcohol-free Hydrogel

NET WT. 0.071 oz. (2g) - 0.71 oz. (20 g)

Distributed by:
Broda International, LLC
10 Barley Court
Plainsboro, NJ 08536
Manufactured and packaged in the USA
www.broda.com

Patent pending

BRODA™

Anti-acne IntelliGel™

Developed with a proprietary break-through IntellGel™ technology that delivers maximum strength acne medication to effectively penetrate pores to clear most acne blemishes and help prevent new acne pimples.

BrodaAcneSpot1 Label

Broda AcneSpot2 Label

Broda AcneSpot3 Label

res

BRODA ACNE  
salicylic acid gel
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:54111-112
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
SALICYLIC ACID (UNII: O414PZ4LPZ) (SALICYLIC ACID - UNII:O414PZ4LPZ) SALICYLIC ACID0.4 g  in 20 g
Inactive Ingredients
Ingredient NameStrength
WATER (UNII: 059QF0KO0R)  
POLOXAMER 407 (UNII: TUF2IVW3M2)  
PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
POLYETHYLENE GLYCOL 400 (UNII: B697894SGQ)  
LAURETH-4 (UNII: 6HQ855798J)  
MENTHOL (UNII: L7T10EIP3A)  
LEVOMENOL (UNII: 24WE03BX2T)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:54111-112-5020 g in 1 TUBE; Type 0: Not a Combination Product10/29/2013
2NDC:54111-112-512 g in 1 TUBE; Type 0: Not a Combination Product10/29/2013
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM00610/29/2013
Labeler - Bentley Laboratories, LLC (068351753)
Establishment
NameAddressID/FEIBusiness Operations
Bentley Laboratories, LLC068351753manufacture(54111-112)

Revised: 12/2023
Document Id: 844e66fe-296b-445d-a44c-7e52e1409db8
Set id: b7e1f105-8998-46a5-b1ae-85d21790b816
Version: 4
Effective Time: 20231218
 
Bentley Laboratories, LLC